This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
VISION Trial
Treatment Considerations in the First Line Setting of mCRPC
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
RSNA 2022
SUO 2022
Urologists for Social Responsibility 2023
Upcoming
ASCO GU 2023
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Bladder Cancer
Conferences
Recent Abstracts
#AUA15 - Crossfire: Controversies in Urology: Neuromodulation should be the first choice over botulinum toxin for idiopathic detrusor overactivity - Session Highlights
May 19, 2015
#AUA15 - Role contemporary pre-cystectomy nomograms at predicting locally advanced and metastatic urothelial bladder cancer - Session Highlights
May 19, 2015
Radium-223 dichloride in expanded-access setting in the United States: Overall and concurrent experience with abiraterone or enzalutamide - Session Highlights
May 19, 2015
#AUA15 - Do primary hormonal therapy outcomes predict subsequent response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer? - Session Highlights
May 19, 2015
#AUA15 - Best of Abstracts: Is retropubic mid-urethral sling safe and effective for patients with Valsalva voiding? - Session Highlights
May 19, 2015
#AUA15 - Magnetic resonance imaging/ultrasound fusion-guided biopsy detects clinically significant prostate cancer in the central gland correlating with the index lesion - Session Highlights
May 19, 2015
#AUA15 - Quality of advanced cancer care in an integrated urology/palliative care clinic - Session Highlights
May 19, 2015
#AUA15 - The consequences of delaying stone treatment - Session Highlights
May 19, 2015
#AUA15 - Prior bladder outflow surgery or large prostate volume does not adversely affect biochemical recurrence-free survival in low dose rate brachytherapy: An intermediate term analysis - Session Highlights
May 19, 2015
#AUA15 - Risk stratification for adverse outcomes following renal mass excision - Session Highlights
May 19, 2015
#AUA15 - Effect of abiraterone acetate and low dose prednisone on prostate-specific antigen in patients with non-metastatic castration-resistant prostate cancer: The results from Impact of Abiraterone Acetate in Prostate-Specific Antigen core study
May 19, 2015
#AUA15 - Assessment of corticosteroid-associated adverse events with long-term exposure to low-dose prednisone given with abiraterone acetate to metastatic castration-resistant prostate cancer patients - Session Highlights
May 19, 2015
#AUA15 - Exploring the incidence of abiraterone acetate withdrawal responses - Session Highlights
May 19, 2015
#AUA15 - Novel antiandrogen ARN-509 in high-risk nonmetastatic castration-resistant prostate cancer - Session Highlights
May 19, 2015
#AUA15 - ALP and bone scan flare following enzalutamide treatment of castration resistant prostate cancer (CRPC) with bone metastasis - Session Highlights
May 19, 2015
#AUA15 - Best of Abstracts: Declining rates of retroperitoneal lymph node dissection for Stage I non-seminomatous germ cell tumors: Results from the National Cancer Database - Session Highlights
May 19, 2015
#AUA15 - Societe Internationale D’Urologie (SIU) Lecture: Redefining optimal surgical management of muscle invasive bladder cancer - Session Highlights
May 19, 2015
#AUA15 - State-of-the-Art Lecture: Bacillus Calmette-Guerin (BCG) refractory carcinoma in situ (CIS) of the bladder - Session Highlights
May 19, 2015
#AUA15 - State-of-the-Art Lecture: Contemporary update on treatment of non-invasive bladder cancer - Session Highlights
May 19, 2015
#AUA15 - AUA census highlights state of urology workforce
May 19, 2015
Page 418 of 492
Start
Prev
413
414
415
416
417
418
419
420
421
422
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free